O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.37M
AUM Growth
-$123K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
153
New
Increased
Reduced
Closed

Top Buys

1
+$110K
2
+$99.3K
3
+$50.1K
4
TMO icon
Thermo Fisher Scientific
TMO
+$45K
5
BLU
BELLUS Health Inc.
BLU
+$33.6K

Top Sells

1
+$168K
2
+$151K
3
+$108K
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$82.9K
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$65.3K

Sector Composition

1 Healthcare 98.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$4.74K 0.09%
+1,123,000
102
$4.63K 0.09%
667,943
-408,597
103
$3.95K 0.07%
4,250,000
104
$3.92K 0.07%
297,382
105
$3.74K 0.07%
411,191
106
$3.31K 0.06%
1,463,251
-121,594
107
$3.2K 0.06%
+1,583,490
108
$3.17K 0.06%
140,685
109
$3.07K 0.06%
128,282
-10,698
110
$2.94K 0.05%
302,591
-1,360
111
$2.8K 0.05%
+220,400
112
$2.69K 0.05%
121,202
113
$2.46K 0.05%
830,641
114
$2.33K 0.04%
2,648,386
115
$2.31K 0.04%
8,466,783
116
$1.67K 0.03%
+848,252
117
$1.37K 0.03%
94,138
-47,752
118
$1.35K 0.03%
18,023
119
$1.17K 0.02%
+640,645
120
$1.14K 0.02%
+38,553
121
$960 0.02%
+117,455
122
$957 0.02%
281,349
123
$945 0.02%
71,889
124
$445 0.01%
5,590
-36,077
125
$422 0.01%
113,500
2 3 4
5
6